Inversago Pharma to Participate at the 2023 SVB Securities Global Biopharma Conference
MONTREAL–(BUSINESS WIRE)– Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced that François Ravenelle,...